Clinical Trial Update: 99Tc-MDP for Thyroid-Associated Ophthalmopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for 99Tc-MDP in Thyroid-Associated Ophthalmopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid-associated Ophthalmopathy

Drugs mentioned

• 99Tc-MDP

Snippet

Sponsor: Dalian University | Conditions: Thyroid-Associated Ophthalmopathy | Phase 4 | Status: COMPLETED